Patents by Inventor Diane Van Alstyne

Diane Van Alstyne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210140980
    Abstract: Methods and compositions useful in treating neurodegenerative disorders are based on septapeptides and extended forms thereof (or portions thereof) that exhibit chemokine activity with respect to microglial cell precursors.
    Type: Application
    Filed: January 3, 2019
    Publication date: May 13, 2021
    Applicant: SEPTA THERAPEUTICS, INC.
    Inventor: Diane VAN ALSTYNE
  • Patent number: 8071102
    Abstract: Novel vaccines include polypeptides that comprise regions corresponding to a chemokine and a hapten. The hapten can be an amino acid sequence corresponding to the Meningitis Related Homologous Antigenic Sequences (MRHAS) of bacterial and viral agents known to cause meningitis. Protective immunity in a host susceptible to meningitis can be induced by inoculating the host with immunogenic amount of such a vaccine.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: December 6, 2011
    Inventors: Diane Van Alstyne, Lawrence R. Sharma
  • Patent number: 5510264
    Abstract: Monoclonal antibodies capable of binding to a Meningitis Related Homologous Antigenic Sequence (MRHAS) are provided. The MRHAS is found in meningitis-causing organisms and chemokines involved in cell chemotaxis. The monoclonal antibodies are useful for detection and diagnosis of meningitis.
    Type: Grant
    Filed: September 28, 1993
    Date of Patent: April 23, 1996
    Assignee: Insight Biotech Inc.
    Inventors: Diane Van Alstyne, Lawrence R. Sharma